Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04675905
Other study ID # PACORUS-D
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date February 1, 2021
Est. completion date October 31, 2022

Study information

Verified date December 2020
Source Heinrich-Heine University, Duesseldorf
Contact Giovanna AL Lurati Buse, MD, MSc
Phone +49-211-8117828
Email giovanna.luratibuse@med.uni-duesseldorf.de
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The PACORUS-D project aims at 1) quantifying the 30-days and 1-year disability burden (assessed using the 12-item WHODAS 2 [WHO Disability Assessment Schedule] questionnaire) after inhospital noncardiac nonneurosurgical procedures ; 2) quantifying the resource utilization up the 1 year after inhospital noncardiac nonneurosurgical procedures; 3) validating days alive and out of hospital (construct and criterion validity) in Germany. PACORUS-D consists of 2 independent cohort: a clinical multicentre cohort to assess "disability" and "days alive and out of hospital" and an administrative cohort to assess "days alive and out of hospital" and "resource utilization" from statutory health insurance data. PACORUS-D is intended as preparatory project in Germany before international expansion. THIS REGISTRATION REFERS TO THE CLINICAL COHORT ONLY.


Description:

Objectives: 1a) to quantify patient-reported disability measured using the 12-item WHO Disability Assessment Schedule (WHODAS) after noncardiac surgery 1. b) to assess the impact of preoperative comorbidities (and frailty in patients aged ≥65 years) and procedural risk, and of postoperative complications on 365-day patient-reported disability after noncardiac surgery; 2. a) to quantify days alive and out of hospital (DAOH), a recently proposed, integrative, easily collected and statistically-efficient outcome after noncardiac surgery; 2b) to validate (construct [convergent] validity) DAOH at 30 and 365 days after noncardiac surgery, i.e. to assess impact of preoperative risk factors/procedural risk and postoperative complications on DAOH; 2c) to assess in a subcohort of patients ≥ 65 years, the construct (convergent) validity of DAOH in terms of frailty (Clinical Frailty Scale); 3a) to evaluate the criterion (concurrent) validity of DAOH for patient-reported disability at 30 days and 365 days; 3b) to evaluate the criterion (predictive) validity of DAOH at 30 days for patient-reported disability at 365 days. In addition to the main study, patients≥ 65 years may opt to participate (separate consent) to a nested cohort study to assess the impact of delirium detected by Confusion Assessment Method (CAM) on 365-day patient-reported disability after noncardiac surgery and on DAOH. Design: prospective multicentre cohort with nested subcohort (Delirium) Eligibility: Inclusion criteria: - aged ≥50 years - non-cardiac, non-neurosurgical surgery (thoracic, vascular, abdominal, urinary tract, or orthopaedic/trauma) - inhospital procedure Patients will be excluded if: - they are unwilling or unable to provide informed consent, - the procedure is cancelled - they are submitted to a procedure requiring only local anesthetics or analgosedation, - they were submitted to ≥1 surgical procedure in the 7 days prior to enrollment - they are unable to complete the WHODAS questionnaire (e.g. language or literacy barriers); - they were previously enrolled in PACORUS. Endpoints: For objectives1a-b and 3a-b, the main endpoint will be "new onset clinically significant disability" at 365 days, defined as an increase in WHODAS score of at least 5% from baseline to a final WHODAS score of at least 35% (Shulman Anesthesiology 2020). For objectives2a-c, the main endpoint will be days alive and out of hospital. The time horizon will be 30 days (primary) and 365 days. Additional endpoints will include "new onset clinically significant disability" at 30 days and "clinical relevant disability" at 30 and at 365 days, defined as 12-item WHODAS exceeding 35% (Shulman Anesthesiology 2020); the continuous WHODAS score at 30 days and 365 days; disability defined at 25%.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 1200
Est. completion date October 31, 2022
Est. primary completion date October 31, 2022
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Eligibility: Inclusion criteria: - aged =50 years - non-cardiac, non-neurosurgical surgery (thoracic, vascular, abdominal, urinary tract, or orthopaedic/trauma) - inhospital procedure Patients will be excluded if: - they are unwilling or unable to provide informed consent, - the procedure is cancelled - they are submitted to a procedure requiring only local anesthetics or analgosedation, - they were submitted to =1 surgical procedure in the 7 days prior to enrollment - they are unable to complete the WHODAS questionnaire (e.g. language or literacy barriers); - they were previously enrolled in PACORUS.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
no intervention (cohort study)
Explanatory variables include preoperative comorbidities, baseline disability, surgical risk, postoperative complications, sex, rural/urban area of residency, Oslo Social Support Scale; Clinical Frailty Scale in patients aged >= 65 years

Locations

Country Name City State
n/a

Sponsors (9)

Lead Sponsor Collaborator
PD Dr. med. MSc Giovanna Lurati Buse German Society of Anesthesiology and Intensive Care (DGAI), Heinrich-Heine University, Duesseldorf, Ruhr University of Bochum, University Hospital Heidelberg, University Hospital of Cologne, University Hospital, Aachen, University Hospital, Bonn, University Hospital, Essen

Outcome

Type Measure Description Time frame Safety issue
Other Clinical relevant disability Definition:12-item WHODAS 2 exceeding 35% (Shulman Anesthesiology 2020); for calculation of WHODAS percentage please refer to outcome 1 30 days and 365 days
Other Continuous 12-item WHODAS 2 score 30 days and 365 days
Other Disability Definition: 12-item WHODAS 2 exceeding 25% (Ustun, Bull World Health Organ, 2010); for calculation of WHODAS percentage please refer to outcome 1 30 days anf 365 days
Primary New onset clinically significant disability applies to objectives 1a-b and 3a-b; Definition:increase in 12-item WHO Disability Assessment Schedule (WHODAS 2) score of at least 5% from baseline to a final WHODAS score of at least 35% (Shulman Anesthesiology 2020); For calculation of the 12-item WHODAS score percentage, the ordinal categories of Linkert scale for each item will be assigned numerical values (none=0 to extreme=4) for a total maximal score of 48 and transformed into the percentage of maximal disability score (Ustun, Bull World Health Organ, 2010); higher percentage indicates higher disability. 365 days
Primary Days alive and out of hospital applies to objective 2a-c 30 days
Secondary New onset clinically significant disability at 30 days applies to objectives 1a-b and 3a-b; Definition see Outcome 1 30 days
Secondary Days alive and out of hospital applies to objective 2a-c 365 days
See also
  Status Clinical Trial Phase
Recruiting NCT02860754 - The Prognostic Capabilities Of A Preoperative Six-Minute Walk Test To Independently Inform Cardiovascular Risk After Major Noncardiac Surgery N/A
Recruiting NCT05703230 - Effects of Preoperative Multidisciplinary Team Meetings for High-risk, Adult, Noncardiac Surgical Patients N/A
Enrolling by invitation NCT04389008 - The Study of Anesthesia-related Risk Factors for Postoperative Death in Elderly Non-cardiac Surgery Patients in China
Completed NCT04527094 - Machine Learning Model to Predict Postoperative Respiratory Failure
Recruiting NCT05536258 - ZYNEX Cardiac Monitor in Patients Having Noncardiac Surgery
Recruiting NCT05812248 - Prediction of Vascular Events After Major Non-Cardiac Surgery : an Observational Prospective Cohort Study